Company: CSL Behring

CSL Behring is a global leader in developing and delivering innovative therapies for patients with serious and rare conditions. Based in the US, the company specializes in protein-based medicines, particularly in the fields of immunology, hemophilia, and critical care. With a commitment to research and development, CSL Behring strives to improve the quality of life for patients worldwide. The company emphasizes patient safety and product effectiveness, ensuring they meet the highest standards in pharmaceuticals.